文献速递糖尿病

糖尿病相关遗传与全胰切除胰岛自体移植后的结局

Diabetes related genetics and outcomes after total pancreatectomy with islet autotransplantation.
PubMed 文献 · J Clin Endocrinol Metab · 2026-09-11

本研究对318例接受全胰切除胰岛自体移植(TPIAT)的慢性胰腺炎患者进行基因分型,评估1型和2型糖尿病遗传风险评分(GRS)及代谢多基因评分(PGS)与移植前糖尿病及移植后1年代谢结局的关联。结果显示,2型糖尿病GRS与移植前糖尿病及较高的移植前HbA1c相关;β细胞PGS与移植后1年较高的胰岛素剂量和IDAA1c相关;脂肪代谢障碍PGS与较高的IDAA1c和较低的空腹C肽相关。糖尿病相关遗传可能影响移植结局并揭示代谢异质性。

要点

  • 2型糖尿病GRS较高者更易在TPIAT前存在糖尿病。
  • β细胞PGS与TPIAT后1年胰岛素需求及IDAA1c升高相关。
  • 脂肪代谢障碍PGS与TPIAT后1年IDAA1c升高和空腹C肽降低相关。

核心结论

  • 2型糖尿病遗传风险与TPIAT前糖尿病相关。
  • β细胞和脂肪代谢障碍PGS与TPIAT后糖尿病结局相关。
  • 糖尿病相关遗传可能影响移植结局并提示代谢异质性。

研究设计与样本

  • 多中心前瞻性观察研究(Advancing Treatment for Pancreatitis: A Prospective Observational Study of TPIAT)。
  • 纳入318例接受TPIAT的慢性胰腺炎患者,使用全球筛查芯片进行基因分型。
  • 采用回归模型评估T1D-GRS、T2D-GRS及代谢PGS与TPIAT后1年糖尿病结局的关联。

主要发现

  • 参与者年龄29±17岁,61%为女性,84%为非西班牙裔白人,13%移植前有糖尿病。
  • 移植前有糖尿病者T2D-GRS更高(-0.6±0.3 vs -0.8±0.2,p=0.003)。
  • T2D-GRS与较高的移植前HbA1c相关(β=0.19 % per 1-SD [95% CI:0.04, 0.33],p=0.011)。
  • 校正基因祖先和胰岛当量/kg后,β细胞PGS与移植后1年较高胰岛素剂量(β=0.05 units/kg/day per 1-SD [95%CI:0.01, 0.09],p=0.016)和较高IDAA1c(β=0.34[95%CI:0.03, 0.67],p=0.029)相关。
  • 脂肪代谢障碍PGS与移植后1年较高IDAA1c(β=0.38 [95%CI:0.06, 0.69],p=0.019)和较低空腹C肽(β=-0.09 [95%CI:-0.18, 0],p=0.041)相关。

临床怎么用

  • 对于接受TPIAT的慢性胰腺炎患者,可考虑糖尿病相关遗传背景评估以预测移植前糖尿病风险。
  • β细胞PGS和脂肪代谢障碍PGS可能有助于识别TPIAT后胰岛素需求较高或血糖控制较差的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Approximately 20% of patients with chronic pancreatitis achieve insulin independence one year after total pancreatectomy with islet autotransplantation (TPIAT), an outcome associated with younger age and lower pre-transplant HbA1c. The contribution of diabetes-related genetics to TPIAT outcomes is unknown. Genetic risk scores (GRS) are associated with C-peptide levels in type 1 (T1D) and type 2 (T2D) diabetes. OBJECTIVE: To evaluate whether T1D and T2D GRS and partitioned metabolic polygenic scores (PGS) are associated with diabetes before TPIAT and metabolic outcomes one year after transplant. METHODS: We genotyped 318 patients with chronic pancreatitis undergoing TPIAT in the multicenter "Advancing Treatment for Pancreatitis: A Prospective Observational Study of TPIAT" using a global screening array. Regression models assessed associations of T1D- and T2D-GRS and metabolic PGS with diabetes outcomes one year after TPIAT. RESULTS: Participants were 29±17 years old, 61% female, 84% non-Hispanic White, and 13% had diabetes prior to transplant. T2D-GRS was higher among those with pre-TPIAT diabetes (-0.6±0.3 versus -0.8±0.2, p=0.003) and was associated with higher pre-transplant HbA1c (β=0.19 % per 1-SD [95% CI:0.04, 0.33], p = 0.011). Adjusted for genotype-derived ancestry and islet equivalents/kg, the beta-cell PGS was associated with higher insulin dose (β=0.05 units/kg/day per 1-SD, [95%CI:0.01, 0.09], p=0.016) and higher insulin dose adjusted A1c (IDAA1c) (β=0.34[95%CI:0.03, 0.67], p=0.029) 1-year post-transplant. The lipodystrophy PGS was associated with higher IDAA1c (β=0.38 [95%CI:0.06, 0.69], p=0.019) and lower fasting C-peptide (β=-0.09 [95%CI:-0.18, 0], p=0.041) at 1 year. CONCLUSIONS: T2D genetic risk is associated with diabetes prior to TPIAT, and beta cell and lipodystrophy PGS are associated with post-TPIAT diabetes outcomes. Diabetes-related genetics may influence transplantation outcomes and inform metabolic heterogeneity.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Triolo TM, Eaton AA, Chen WM, et al. Diabetes related genetics and outcomes after total pancreatectomy with islet autotransplantation. J Clin Endocrinol Metab. 2026. PMID: 42722448. doi:10.1210/clinem/dgag355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。